First Page | Document Content | |
---|---|---|
Date: 2017-01-08 10:42:07 | CDKL5 Program of Excellence Pilot Grant Program Application Title: Development of TALE and CRISPR/Cas9 as a putative therapy for treatment or correction of genetically linked CDKL5 Deficiency PI: Jan Nolta, PhD InstitutiAdd to Reading ListSource URL: www.louloufoundation.orgDownload Document from Source WebsiteFile Size: 260,27 KBShare Document on Facebook |